drugset / Trial / NCT00542009
A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight
RandomizedParallel-groupDouble-blindTreatment
Summary
Study of whether the investigational drug CE-326,597 improves glucose control and results in body weight loss in patients with type 2 diabetes
Timeline
- Start
- 2007-12
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CE-326,597 | Small molecule | 5 mg | Oral |
| Subject | CE-326,597 | Small molecule | 25 mg | Oral |
| Subject | CE-326,597 | Small molecule | 50 mg | Oral |
| Subject | CE-326,597 | Small molecule | 100 mg | Oral |
Indications
No indication recorded.